RESEARCH
Effect of age on the pharmacokinetics of fimasartan (BR-A-657)
Lee HW, Lim MS, Seong SJ, Lee J, Park J, Seo JJ, Cho JY, Yu KS, Yoon YR.
Expert Opin Drug Metab Toxicol 2011,Nov;7(11):1337-44
The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers
Shin KH, Kim TE, Kim SE, Lee MG, Song IS, Yoon SH, Cho JY, Jang IJ, Shin SG, Yu KS.
J Cardiovasc Pharmacol 2011,Nov;58(5):492-9
Imunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults
Lee S, Park WB, Shin KH, Ahn DH, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.
Vaccine 2011,Oct;29(44):7638-43.
Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel
Jung KH, Chu K, Lee ST, Yoon HJ, Chang JY, Nam WS, Yoon SH, Cho JY, Yu KS, Jang IJ, Kim M, Lee SK, Roh JK.
Clin Pharmacol Ther 2011,Oct;90(4):612-9
Population pharmacokinetic analysis and dosing regimen optimization of aprotinin in neonates and young infants undergoing cardiopulmonary bypass
Tae YM, Kwak JG, Kim BH, Jang IJ, Kim WH.
J Clin Pharmacol 2011,Aug;51(8):1163-76
Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers
Lee SH, Kim BH, Nam WS, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.
J Clin Pharmacol 2011,Jul;[Epub ahead of print]
Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis
Kim K, Hwang YH, Ro H, Oh YK, Kim MG, Yu KS, Shin KH, Jang IJ, Shin SG, Ann C, Oh KH.
Antimicrob 2011,Jun;55(6):2523-7. Epub 2011 Mar 14.
Pharmacokinetic Interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers
Yi SJ, Kim TE, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.
J Cardiovasc Pharmacol 2011,Jun;57(6):682-9
Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
Kang HR, Jee YK, Kim YS, Lee CH, Jung JW, Kim SH, Park HW, Chang YS, Jang IJ, Cho SH, Min KU, Kim SH, Lee KW.
Pharmacogenet Genomics 2011,May;21(5):303-7.
Effect of multiple doses of fimasartan, an angiotension II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers
Yi SJ, Kim JW, Kim TE, Kim J, Jun YK, Choi J, Yoon SH, Cho JY, Song SH, Shin SG, Jang IJ, Yu KS.
Int J Clin Pharmacol Ther 2011,May;49(5):321-7
Effects of pregnane X receptor (NR1I2) and CYP2B6 genetic polymorphisms on the induction of bupropion hydroxylation by rifampin
Chung JY, Cho JY, Lim HS, Kim JR, Yu KS, Lim KS, Shin SG, Jang IJ.
Drug Metab Dispos 2011,Jan; 39(1):92-7
The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarin
Jung JW, Kang HR, Kwon JW, Kim TE, Lee SH, Hong KS, Yu KS, Cho SH. Tohoku
J Exp Med 2011,Jan;224(4):293-300